SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000874015-16-000118
Filing Date
2016-05-05
Accepted
2016-05-04 18:34:40
Documents
55
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 IONIS PHARMACEUTICALS INC 10-Q 3-31-2016 form10q.htm 10-Q 955627
2 EXHIBIT 10.1 ex10_1.htm EX-10.1 39347
3 EXHIBIT 10.2 ex10_2.htm EX-10.2 92332
4 EXHIBIT 31.1 ex31_1.htm EX-31.1 8091
5 EXHIBIT 31.2 ex31_2.htm EX-31.2 7743
6 EXHIBIT 32.1 ex32_1.htm EX-32.1 6140
  Complete submission text file 0000874015-16-000118.txt   6104460

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT ions-20160331.xml EX-101.INS 1159132
8 XBRL TAXONOMY EXTENSION SCHEMA ions-20160331.xsd EX-101.SCH 57734
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ions-20160331_cal.xml EX-101.CAL 72177
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ions-20160331_def.xml EX-101.DEF 385563
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE ions-20160331_lab.xml EX-101.LAB 743839
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ions-20160331_pre.xml EX-101.PRE 463568
Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address 2855 GAZELLE COURT CARLSBAD CA 92010 7609319200
IONIS PHARMACEUTICALS INC (Filer) CIK: 0000874015 (see all company filings)

IRS No.: 330336973 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19125 | Film No.: 161621030
SIC: 2834 Pharmaceutical Preparations